¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fat induced hyperlipemia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® fat ÇÑ±Û Áö¹æ
¼³¸í   
  1. Áö¹æÁ¶Á÷À» ³ªÅ¸³»´Â ¸». Áï Èò»öÀ̳ª ³ë¶õ»öÀ» ¶ì´Â ¿¡³ÊÁö¸¦ º¸°üÇϴ ±â´ÉÀ» Çϴ Á¶Á÷. ¿©·¯ °¡Áö ±â°üµé »çÀÌ¿¡ Á¸ÀçÇÑ´Ù. 2. Áö¹æ»ê°ú ±Û¸®¼¼·ÑÀÌ °áÇÕÇÑ À¯±â È­ÇÕ¹°. »ó¿Â¿¡¼­ °íüÀÇ ÇüÅÂÀ̸ç, »ý¹°Ã¼¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Ù. µ¿¹°¿¡¼­´Â ÇÇÇÏ-±ÙÀ°-°£ µûÀ§¿¡ ÀúÀåµÇ¸ç, ¿¡³ÊÁö¿øÀÌÁö¸¸ ¸ö¹«°Ô°¡ ´À´Â ¿øÀÎÀÌ µÇ±âµµ ÇÑ´Ù. ±Û¸®¼¼·ÑÀÌ 3°¡ÀÇ ¾ËÄÚ¿ÃÀ̹ǷΠÁö¹æ»êÀº ¼Â±îÁö °áÇÕÇÒ ¼ö Àִµ¥, Áö¹æ»êÀÌ Çϳª °áÇÕÇÑ °ÍÀ» ¸ð³ë¾Æ½Ç±Û¸®¼¼·Ñ(monoacylglycerol) µÑÀÌ °áÇÕÇÑ °ÍÀ» µð¾Æ½Ç±Û¸®¼¼·Ñ(diacylglycerol) ¼ÂÀÌ °áÇÕÇÑ °ÍÀ» Æ®¸®¾Æ½Ç±Û¸®¼¼·Ñ(triacylglycerol) À̶ó°í ÇÑ´Ù. »ýü³»ÀÇ ¸ð³ë¾Æ½Ç±Û¸®¼¼·Ñ ¹× µð¾Æ½Ç±Û¸®¼¼·ÑÀº ±ØÈ÷ ÀûÀº ¾çÀÌÁö¸¸, ÁöÁú´ë»ç¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù. Æ®¸®¾Æ½Ç±Û¸®¼¼·ÑÀº ±Û¸®ÄÚ°Õ°ú ÇÔ²² ÀúÀå¿¡³ÊÁö·Î µÇ¾î ÀÖ´Ù.
¿µ¹® saturated fat ÇÑ±Û Æ÷È­Áö¹æ
¼³¸í   
  Åº¼Ò °áÇÕÀÌ ¸ðµÎ ´ÜÀÏ °áÇÕÀ¸·Î ±¸¼ºµÈ Áö¹æ»êÀ¸·Î ÀÌ·ç¾îÁø Áö¹æÀ» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperlipemia
    °íÁöÁúÇ÷Áõ
  • body fat
    üÁö¹æ, ¸öÁö¹æ
  • brown fat
    °¥»öÁö¹æ
  • buccal fat pad
    º¼Áö¹æµ¢ÀÌ, º¼Áö¹æÃ¼
  • fat
    Áö¹æ
  • fat atrophy
    Áö¹æÀ§Ãà
  • fat blood level
    Áö¹æÇ÷Ãþ
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat deficiency disease
    Áö¹æ°áÇ̺´
  • fat depot
    ÀúÀåÁö¹æ
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat metabolism
    Áö¹æ´ë»ç
  • fat necrosis
    Áö¹æ±«»ç
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • fat-free body mass
    Áö¹æÁ¦¿ÜüÁß
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperlipemia
    °íÁöÁúÇ÷Áõ
  • steroid-induced glaucoma
    ½ºÅ×·ÎÀ̵å³ì³»Àå
  • pregnancy-induced hypertension
    ÀӽŰíÇ÷¾Ð
  • induced
    À¯¹ß-, À¯µµ-
  • induced labor
    À¯µµºÐ¸¸
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat
    Áö¹æ
  • body fat
    ¸öÁö¹æ, üÁö¹æ
  • milk fat
    ¿ìÀ¯Áö¹æ, À¯Áö¹æ
  • subcutaneous fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • traumatic fat necrosis
    ¿Ü»óÁö¹æ±«»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fat induced hyperlipemia
    ÁöÁúÀ¯µµ°íÁö¹æÇ÷Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperlipemia
    °íÁö¹æÇ÷Áõ
  • fat atrophy
    Áö¹æÀ§Ãà
  • body fat
    ¸öÁö¹æ, üÁö¹æ
  • buccal fat pad
    º¼Áö¹æµ¢ÀÌ
  • buccal fat pad excision
    º¼Áö¹æÃ¼ÀýÁ¦¼ú
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat-storing cell
    Áö¹æÀúÀå¼¼Æ÷
  • depot fat
    ÀúÀåÁö¹æ
  • fat deficiency disease
    Áö¹æ°áÇÌÁõ
  • mutton fat deposit
    ±»±â¸§Ä§Âø¹°
  • elbow fat pad sign
    ÆÈ²ÞÄ¡Áö¹æÆÐµå¡ÈÄ
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat
    Áö¹æ
  • fat-soluble
    Áö¿ë¼º-
  • fascia-fat flap
    ±Ù¸·Áö¹æÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fat
    Áö¹æ(ò·Û¸)
  • Fat cells
    Áö¹æ(ò·Û¸)¼¼Æ÷(á¬øà)
  • Fat-soluble vitamins
    Áö¿ë¼º(ò·éÁàõ)ºñŸ¹Î
  • frequency selective fat suppression technique
    Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦(±â)¹ý
  • half fat cheese
    ¹ÝÅ»ÁöÄ¡ÀÌÁî.
  • high fat diet
    °íÁö¹æ½ÄÀÌ.
  • hypodermic fat
    ÇÇÇÏÁö¹æ(¡­ò·Û¸).
  • infrapatellar fat pad
    ½½°³ÇÏ Áö¹æÃ¼(ã£ËÏù»ò· Û¸ô÷), ½½°³ÇÏ Áö¹æ ÆÐµå.
  • infrapatellar fat pad
    ¹«¸­¹ØÁö¹æ
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
  • Lhermittes syndrome, radiation-induced
    ¹æ»ç¼±À¸·Î À¯¹ßµÈ ·¹¹ÌÅ× ÁõÈıº
  • NIHL [=noise induced hearing loss]
    ¼ÒÀ½¼º ³­Ã»
  • T1 induced dephasing
    T1 À¯µµ Å»À§»ó
  • abactio =induced abortion, abactus venter<³ª>
    ÀΰøÀ¯»ê(ìÑÍïêüß§).
  • antibiotic-induced colitis (AAC)
    Ç×»ýÁ¦À¯¹ß´ëÀå¿°, Ç×»ýÁ¦À¯¹ß¼³»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fat induced hyperlipemia
    ÁöÁúÀ¯µµ¼º °íÁö¹æÇ÷Áõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bone fat
    °ñÁö(Íéò·).
  • breast,traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ±«»ç (èâß¿àõò·Û¸ÎÕÞÝ)
  • brown fat
    ºê¶ó¿î Áö¹æ(ò·Û°)
  • brown fat
    °¥»öÁö¹æ(ü)(¡­ò·Û¸ô÷).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷(¡­ò·Û¸ðÚòÄ).
  • brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
  • depot fat
    ÀúÀåÁö¹æ(îÍíúò·Û¸).
  • elbow fat pad sign
    ÆÈ²ÞÄ¡ Áö¹æ ÆÐµå¡ÈÄ(~ó£ý¦).
  • embolism,fat
    Áö¹æ(ò·Û¸)
  • fat
    Áö¹æ(ò·Û¸).
  • fat atrophy
    Áö¹æ À§Ãà
  • fat blood level
    Áö¹æÇ÷ Ãþ
  • fat cell
    Áö¹æ¼¼Æ÷(¡­á¬øà).
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat column
    Áö¹æÁÖ(ò·Û¸ñº).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Induced ovulation
    À¯µµ¹è¶õ
    [¿¾ ¿ë¾î] À¯µµ¹è¶õ
  • Brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
    [¿¾ ¿ë¾î] °¥»öÁö¹æÁ¶Á÷
  • Fat-storing cell
    µ¿±¼ÁÖÀ§Áö¹æ¼¼Æ÷
    [¿¾ ¿ë¾î] µ¿¾çÇ÷°üÁÖÀ§Áö¹æ¼¼Æ÷
  • Infrapatellar fat pad
    ¹«¸­¹ØÁö¹æ
    [¿¾ ¿ë¾î] ½½°³ÇÏÁö¹æÃ¼
  • Multilocular fat cell
    ¹µÄ­Áö¹æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´Ù¹æ¼ºÁö¹æ¼¼Æ÷
  • White fat tissue
    ¹é»öÁö¹æÁ¶Á÷
    [¿¾ ¿ë¾î] ¹é»öÁö¹æÁ¶Á÷
  • Fat droplet
    Áö¹æ¹æ¿ï
    [¿¾ ¿ë¾î] Áö¹æÀû
  • Pararenal fat pad
    ÄáÆÏÁÖÀ§Áö¹æÃ¼
    [¿¾ ¿ë¾î] ½ÅÀ广Áö¹æÃ¼
  • Unilocular fat cell
    ȬĭÁö¹æ¼¼Æ÷
    [¿¾ ¿ë¾î] ´Ü¹æ¼ºÁö¹æ¼¼Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • induced malaria
    Á¢Á¾¸»¶ó¸®¾Æ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperlipemia
    °úÁöÁúÇ÷Áõ(Φò·òõúìñø)
  • brown fat
    °¥»öÁö¹æ(Êèßäò·Û¸)
  • depot fat
    ÀúÀåÁö¹æ(îÍíúò·Û¸)
  • fat
    Áö¹æ(ò·Û¸)
  • fat body
    Áö¹æÃ¼(ò·Û¸ô÷)
  • fat-soluble A
    Áö¿ë¼º(ò·éÁàõ) A
  • fat solvent
    Áö¹æ ¿ë¸Å(ò·Û¸éÁØÚ)
  • fat-splitting
    Áö¹æ ºÐÇÒ(ò·Û¸ÝÂùÜ)
  • neutral fat
    Áß¼ºÁö¹æ(ñéàõò·Û¸)
  • true fat
    Áø¼ºÁö¹æ(òØàõò·Û¸)
  • white fat
    ÈØ Áö¹æ (ò·Û¸)
  • wool fat
    ¾çÅÐÁö¹æ(ò·Û¸)
  • aldosterone-induced protein
    ¾Ëµµ½ºÅ×·ÐÀ¯µµ ´Ü¹éÁú(ë¯ÓôÓ±ÛÜòõ)
  • dipole-induced dipole interaction
    ½Ö±ØÀÚÀ¯µµ ½Ö±ØÀÚ »óÈ£ÀÛ¿ë(äªÐ¿í­ë¯ÓôäªÐ¿í­ßÓû»íÂéÄ)
  • host-induced modification
    ¼÷ÁÖÀ¯µµ ¼ö½Ä(âÖñ«ë¯ÓôáóãÞ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • induced
    À¯µµµÈ, À¯¹ßµÈ, ÀÀÇÑ
  • radiation induced cancer
    ¹æ»ç¼±À¯¹ß¾Ï
  • T1 induced dephasing
    T1À¯µµÅ»À§»ó
  • fat
    Áö¹æ
  • fat blood level
    Áö¹æÇ÷Ãþ
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat degeneration
    Áö¹æº¯¼º
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat globule
    Áö¹æ±¸
  • fat image
    Áö¹æ¿µ»ó
  • fat infiltration
    Áö¹æÄ§À±
  • fat meal
    Áö¹æ½Ä
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • fat plane
    Áö¹æ¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EHL effective half-life; electrohydraulic lipotripsy; endogenous hyperlipidemia; Environmental Health La...
SIH stimulation-induced hypalgesia; stress-induced hyperthermia; suction-induced hypoxemia
BF bentonite flocculation; bile flow; black female; blastogenic factor; blister fluid; blood flow; body...
FIH familial isolated hypoparathyroidism; fat-induced hyperglycemia
DIT deferoxamine infusion test; diet-induced thermogenesis; diiodotyrosine; drug-induced thrombocytopeni...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
% FAT fat
AF Abdominal fat
AVF Abdominal visceral fat
BF Body fat
BFM Body fat mass
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • elbow fat pad sign
    ÆÈ²ÞÄ¡ Áö¹æ ÆÐµå ¡ÈÄ
  • fat
    Áö¹æ, Áö¹æ Á¶Á÷
    ¹é»öÀ̳ª ´ãȲ»öÀÇ Á¶Á÷À¸·Î ½ÅüÀÇ ¿©·¯ ±â°ü »çÀÌ¿¡¼­ ¿¬ÇÑ ÆÐµå¸¦ Çü¼ºÇÏ¿© ½ÅüÀÇ À±°ûÀ» ºÎµå·´°Ô Çϰųª ¿¡³ÊÁöÀÇ ÀúÀå ¿ªÇÒÀ» ÇÑ´Ù. ±Û¸®¼¼¸° Áö¹æ»ê ¿¡½ºÅÍ.
  • fat cell
    Áö¹æ ¼¼Æ÷
  • fat degeneration
    Áö¹æ º¯¼º
  • fat embolism syndrome
    Áö¹æ »öÀü ÁõÈıº
    Áö¹æ ¼ººÐÀÌ ´ëºÎºÐÀΠȲ»ö °ñ¼ö·Î µÈ °ñÀÇ °ñÀý ¶Ç´Â Áö¹æ Á¶Á÷ÀÇ ½ÉÇÑ ¿Ü»ó ÈÄ¿¡ Á¡ÁøÀû Æó ºÎÀüÁõ, Á¤½Å·Â ÀúÇÏ¿Í ½Å ºÎÀüÁõÀ» ÃÊ·¡ÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. ÀÌ´Â ÆÄ¿­µÈ Ç÷°ü ¼ÓÀ¸·Î ¹«¼öÇÑ Áö¹æ±¸°¡ µé¾î°¡ ¿©·¯ Àå±â¿¡ ºÐÆ÷ÇÑ Ç÷°ü¿¡ »öÀüÁõÀ» ¾ß±âÇÔÀ¸·Î½á ÀϾ´Ù. ÀϹÝÀûÀ¸·Î º´ÀηÐÀº º¹ÇÕÀûÀÌ´Ù. ÀÏ´Ü ÀÌ ÁõÈıºÀÌ ¹ß»ýÇÏ¸é ¸Å¿ì À§µ¶ÇÏ¿© ´ë·« 10-15%ÀÇ »ç¸Á·üÀ» ³ªÅ¸³½´Ù.
  • fat graft
    Áö¹æ ÀÌ½ÄÆí, Áö¹æ À̽Ä
    ÁöÁö Á¶Á÷¿¡¼­ ¿ÏÀüÈ÷ À¯¸®½ÃŲ Áö¹æÀÇ À̽Ä. ÇÔ¸ôºÎ¸¦ ¸Þ¿ì±â À§ÇØ »ç¿ëÇÑ´Ù.
  • fat infiltration
    Áö¹æ ħÀ±
  • fat necrosis
    Áö¹æ ±«»ç
  • fat plane
    Áö¹æ ¸é
  • fat soluble
    Áö¿ë¼ºÀÇ
  • fat suppression
    Áö¹æ ¾ïÁ¦
  • frequency selective fat suppression technique
    ÁÖÆÄ ¼ö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý, Á֯ļö ¼±Åà Áö¹æ ¾ïÁ¦ ±â¹ý
  • hypodermic fat
    ÇÇÇÏ Áö¹æ
    ÇÇÇÏ Á¶Á÷¿¡ Á¸ÀçÇÏ´Â Áö¹æÃþ.
  • multilocular fat cell
    ¹µÄ­ Áö¹æ ¼¼Æ÷
  • pararenal fat pad
    ÄáÆÏ ÁÖÀ§ Áö¹æÃ¼
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
familial combined hyperlipemia familial hyperlipoproteinemia
combined fat-and carbohydrate-induced hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
familial fat-induced hyperlipaemia Hyperlipoproteinaemia characterised by the presence of large amounts of chylomicrons and triglycerides in the plasma when the patient has a normal diet, and their disappearance on a fat-free diet; low alpha-and beta-lipoproteins on a normal diet, with increase on fat-free diet; decreased plasma postheparin lipolytic activity; and low tissue lipoprotein lipase activity. It is accompanied by bouts of abdominal pain, hepatosplenomegaly, pancreatitis, and eruptive xanthomas; autosomal recessive inheritance.
See: familial lipoprotein lipase inhibitor.
Synonym: Burger-Grutz syndrome, familial fat-induced hyperlipaemia, familial hyperchylomicronaemia, familial hypertriglyceridemia, idiopathic hyperlipaemia.
(05 Mar 2000)
abdominal wall fat pad biopsy <investigation, procedure, surgery> The removal of a small specimen of the abdominal wall fat pad for microscopic examination. Often used in the diagnosis of amyloidosis. Performed with a local anaesthetic.
(25 Jun 1999)
abnormalities, drug-induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
(12 Dec 1998)
abnormalities, radiation-induced Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation.
(12 Dec 1998)
abortion, induced Intentional removal of a foetus from the uterus by any of a number of techniques. (popline, 1978)
(12 Dec 1998)
akathisia, drug-induced Motor restlessness with sensations of quivering and an urge to move about constantly resulting from the use of certain drugs, such as neuroleptic drugs, which affect the extrapyramidal region of the brain. This differs from dyskinesia, drug-induced in that long-term antipsychotic drug exposure is significantly correlated with the increased prevalence of akathisia while there is no such correlation with dyskinesia. The primary observable distinction between tardive akathisia and dyskinesia appears to be in the repetitive, stereotypy of the dyskinesic movements (lip smacking, for example), while akathisia is associated with anxiety, restlessness, and agitation (psychomotor agitation).
(12 Dec 1998)
alpha-chymotrypsin-induced glaucoma Transient secondary glaucoma following the use of alpha-chymotrypsin in cataract extraction.
(05 Mar 2000)
antibiotic induced enteritis <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms.
(27 Sep 1997)
antibiotic induced gastroenteritis <pathology> A condition where the normal intestinal bacteria (useful for digestion) are killed by the use of an antibiotic resulting in symptoms.
(27 Sep 1997)
antibody induced lysis <haematology> The term is imprecise and should not be used since there is confusion as to which mechanism is involved, i.e. Natural killing or complement lysis.
See: complement lysis, natural killer cells.
(09 Feb 1998)
asthma, exercise-induced Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. Inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it).
(12 Dec 1998)
bacteriophage T7 induced DNA polymerase <enzyme> Complex of two proteins, phage gene 5 protein and E coli thioredoxin
Registry number: EC 2.7.7.-
Synonym: t7 phage DNA polymerase, sequenase, t7 DNA polymerase, thermo sequenase
(26 Jun 1999)
Bichat's fat-pad An encapsuled mass of fat in the cheek on the outer side of the buccinator muscle, especially marked in the infant; supposed to strengthen and support the cheek during the act of sucking.
Synonym: corpus adiposum buccae, Bichat's fat-pad, Bichat's protuberance, fat body of cheek, sucking cushion, sucking pad, suctorial pad.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • induced drag
    (°ø)À¯µµÇ×·Â
  • hyperlipemia
    Áö¹æ °úÀ×Ç÷
  • hyperlipemia
    °íÁö¹æÇ÷(Áõ);Áö¹æ °úÀ×Ç÷(Áõ);=hyperlipidemia
  • fat
    ¶×¶×ÇÑ,±â¸§±â,¶×¶×ÀÌ
  • fat
    »ìÂð;Áö¹æÀÌ ¸¹Àº;ºñ¿ÁÇÑ;dzºÎÇÑ;À¯º¹ÇÑ;µÐ°¨ÇÑ;Áö¹æ;±â¸§±â;Á¦ÀÏÁÁÀº ºÎºÐ;»ìÂî(°ÔÇÏ)´Ù
  • fat cat
    Á¤Ä¡ ÀÚ±ÝÀ» ¸¹ÀÌ ¹ÙÄ¡´Â ºÎÀÚ;¼¼·Â°¡;À¯¸íÀÎ;µ· ¸¹Àº Ư±ÇÀÎ
  • fat city
    ´õÇÒ ¼ö ¾øÀÌ ÁÁÀº »óÅÂ(»óȲ,Àü¸Á)
  • fat farm
    =health spa
  • fat farm
    »ì»©´Â µµÀå
  • fat lamb
    ºñÀ° »õ³¢¾ç
  • fat lime
    ºÎ¼®È¸
  • green fat
    ¹Ù´Ù°ÅºÏÀÇ ±â¸§(Áø¹Ì)
  • puppy fat
    (À¯¾Æ±â,»çÃá±âÀÇ ÀϽÃÀû) ºñ¸¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á